Authors evaluated NSCLC outcomes in patients treated with cisplatin-based chemotherapy who were selected by using radiation planning parameters. Annals of Oncology
The tests that are currently available, mainly focused on measuring blood in the urine, have a low positive predictive value. br / iMedscape Medical News/i
Results from the QUASAR trial show that adjuvant chemotherapy with fluorouracil improves survival in patients with stage 2 colorectal cancer, although the benefit is small. Medscape Medical News